ArriVent BioPharma, Inc.(AVBP)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

ArriVent BioPharma, Inc. (AVBP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AVBP is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of AVBP by reported 13-F value include SUVRETTA CAPITAL MANAGEMENT, INFINITUM ASSET MANAGEMENT, Hillhouse Capital Advisors, Ltd., based on the most recent SEC filings. AVBP trades on the Nasdaq exchange and files with the SEC under CIK 1868279. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVBP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ArriVent BioPharma, Inc. directly from SEC EDGAR.